
Founding Member
A founding member of the Association of Multisite Research Corporations
Alcanza Clinical Research is a founding member of the newly launched Association of Multisite Research Corporations (AMRC). By joining forces with 13 other prominent multisite organizations, AMRC aims to transform how clinical trials are conducted across the U.S.
AMRC brings together an extensive network of over 400 research sites, almost 1,000 Principal Investigators (PIs), and more than 7,000 research professionals. In just 2024, AMRC members have collectively enrolled over 73,500 patients into clinical trials, highlighting the strength and reach of aligned site networks.
AMRC’s Mission Delivers Key Benefits:
- Minimize delays impacting nearly 80% of clinical trials
- Improve operational efficiency to keep pace with increasingly complex study designs
- Strengthen collaboration, standardization, and data quality to speed drug development and deliver better patient outcomes
This alliance marks a pivotal move toward faster, more reliable research execution—and Alcanza is proud to help shape a clinical research future that is inclusive, compassionate, impactful, and determined.




